RBPJ and myeloid sarcoma: While early research showed a high frequency of anti-CSL antibodies in the CSF of individuals with MS—with notable sensitivity and specificity in younger patients—these antibodies are also detected, though less frequently, in other neurological conditions and in older individuals [66,67].